Results 191 to 200 of about 167,864 (314)

Introducing self‐sampling for cervical cancer screening: A regional implementation study in Pirkanmaa, Finland

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
In this pilot study, HPV self‐sampling reached a 1.9% uptake among screening non‐attenders. Participants found the method acceptable, although overall screening coverage did not increase during the first implementation year. Abstract Introduction HPV primary testing is the preferred method for cervical cancer screening worldwide and enables vaginal ...
Saara Kyllönen   +4 more
wiley   +1 more source

Human papillomavirus persistence and clearance in women living with HIV: A five‐year retrospective analysis from an Italian university center

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea   +10 more
wiley   +1 more source

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson   +2 more
wiley   +1 more source

Cervical human papillomavirus: the therapeutic target of botanical drugs. [PDF]

open access: yesFront Pharmacol
Tang YC   +4 more
europepmc   +1 more source

The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection

open access: yesBJU International, EarlyView.
Background Penile cancer is a rare malignancy, with an Australian incidence of 0.6 in 100 000 men, with a wide range of clinical presentations, from localised, curable tumours to aggressive forms with high morbidity and mortality. Epidemiological data and management guidelines for penile cancer in Australia are limited.
Henry Y.C. Pan   +11 more
wiley   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

open access: yesBritish Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy